Australia markets open in 9 hours 10 minutes

    +29.00 (+0.43%)

    +0.0011 (+0.17%)
  • ASX 200

    +26.80 (+0.41%)
  • OIL

    +2.23 (+2.91%)
  • GOLD

    +9.00 (+0.55%)

    +1,405.26 (+4.71%)
  • CMC Crypto 200

    +2.91 (+0.63%)

Taliban says it has a deal to sell cannabis in Australia, but firm denies involvement

·3-min read
A farmer works at a cannabis plantation in the Panjwai district of Kandahar on October 13, 2021. (Source: Getty)
The Taliban have claimed they have sealed a deal to supply cannabis products to an Australian firm. (Source: Getty)

The Taliban claim they have struck their first deal to legally grow and manufacture cannabis products for Australia and have entered into a US$400+ million ($625+ million) agreement with an Australian medical consulting firm Cpharm.

Twitter posts from the Afghan Ministry of Interior Affairs claimed that Cpharm has agreed to invest more than US$400 million ($625) to set up a hashish processing plant in Afghanistan.

"This project, which is expected to be functional soon will give Cpharm access to thousands of acres of Afghan cannabis crops and also give hundreds of people job opportunities,” the ministry said in a tweet.

Australian company Cpharm however, has clearly denied these claims.

Also read: 200,000 migrants will stretch our property markets next year

Also read:The $100,000 fertility question no one wants to talk about

Also read: 21-year old fined $4,000 for partying and shopping

"Cpharm is a family business with a 17- member staff from the regional centre of Maitland and has never spoken to the Taliban and has no dealings overseas or involving cannabis" the company told Reuters.

A press release by the company said, “We have become aware overnight of numerous media articles stating that Cpharm in Australia has been involved in a deal with the Taliban to be involved in the supply of cannabis in a cream."

Cpharm further clarified, “We DO NOT manufacturer or supply anything. We provide a medical advice service to the pharmaceutical industry within Australia. We have no products on the ARTG (Australian Register of Therapeutic Goods). We have no connection with cannabis or the Taliban. We have no idea where the Taliban media release has come from and want to assure everyone that it should not be connected to Cpharm Pty Ltd Australia.”

In this photograph taken on October 28, 2021, a boy works in a cannabis field on the outskirts of Kandahar. Afghanistan's new Taliban authorities swear they plan to crack down on the illicit drugs trade that largely fuelled their successful revolt. (Source: Getty)
Cpharm has clarified that there is no truth to Taliban's claims that they have entered into a deal to grow and manufactuare cannabis products for Australia. (Source: Getty)

Qari Saeed Khosty, a spokesperson for the Taliban, had released details in a Twitter thread about the supposed deal.

The translation of his tweet reads, “Yesterday, officials from the Ministry of Interior’s Counter-Narcotics Department met with a representative of the company (Cpharm). The company wants to build a cannabis processing plant in Afghanistan, which will create all cannabis products."

He further goes on to say, "In Afghanistan, only this company will be legally contracted. By establishing this factory, Cpharm Company will use cannabis produced in Afghanistan to make spices and a kind of cream.”

The Associated Press has previously reported that soon after the Taliban came into power in Afghanistan, they went on a rampage conducting raids on drug consumers and threatened them with harsh violence if they did not agree to enter into treatment.

In 2001, the Taliban banned the production of opium before the US military invasion.

ow it appears as though they see economic opportunities again—but through a more professional, regulated market, as reported by Al Arabiya.

Update as on Nov 26, 2021: Following the misunderstanding, a Taliban spokesman has since told SBS the US$450 million ($631) cannabis deal is with a German company, not the Australian company they named in an official tweet.


Follow Yahoo Finance on Facebook, LinkedIn, Instagram and Twitter, and subscribe to the free Fully Briefed daily newsletter.